Eric M Dube is CHIEF EXECUTIVE OFFICER of Travere Therapeutics, Inc.. Currently has a direct ownership of 361,975 shares of TVTX, which is worth approximately $6.61 Million. The most recent transaction as insider was on Feb 02, 2021, when has been sold 8,734 shares (Common Stock) at a price of $30.18 per share, resulting in proceeds of $263,592. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 362K
3.24% 3M change
49.21% 12M change
Total Value Held $6.61 Million

Eric M Dube Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 02 2021
SELL
Open market or private sale
$263,592 $30.18 p/Share
8,734 Reduced 5.46%
151,345 Common Stock
Jan 31 2021
BUY
Grant, award, or other acquisition
-
15,000 Added 8.57%
160,079 Common Stock
Jan 21 2021
BUY
Grant, award, or other acquisition
-
57,260 Added 28.3%
145,079 Common Stock
Jan 06 2021
SELL
Open market or private sale
$92,860 $27.01 p/Share
3,438 Reduced 3.77%
87,819 Common Stock
Jan 05 2021
SELL
Open market or private sale
$91,623 $26.65 p/Share
3,438 Reduced 3.63%
91,257 Common Stock

Also insider at

RPHM
Reneo Pharmaceuticals, Inc. Healthcare
EMD

Eric M Dube

CHIEF EXECUTIVE OFFICER
San Diego, CA

Track Institutional and Insider Activities on TVTX

Follow Travere Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TVTX shares.

Notify only if

Insider Trading

Get notified when an Travere Therapeutics, Inc. insider buys or sells TVTX shares.

Notify only if

News

Receive news related to Travere Therapeutics, Inc.

Track Activities on TVTX